Reproducibility studies and interlaboratory concordance for androgen assays in female plasma

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 4, 2000, Pages 403-412

  Fears, Thomas R ^a   Ziegler, Regina G ^a   Donaldson, Jennifer L ^a   Falk, Roni T ^a   Hoover, Robert N ^a   Stanczyk, Frank Z ^b   Vaught, Jimmie B ^c   Gail, Mitchell H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (United States)

^c MA BioServices Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTENEDIONE; ANDROSTERONE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; FOLLICULAR PHASE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LUTEAL PHASE; MENSTRUAL CYCLE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY; TECHNIQUE;

ADULT; ANDROGENS; BREAST NEOPLASMS; CLINICAL CHEMISTRY TESTS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; LABORATORIES; MENOPAUSE; MENSTRUATION; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 0034064797     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bernstein, L., and Ross, R. K. Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15: 48-65, 1993.
2. Pike, M. C., Spicer, D. V., Dalmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
3. Kuller, L. H. The etiology of breast cancer - from epidemiology to prevention. Public Health Rev., 23: 157-213, 1995.
4. Key, T. J. A., and Pike, M. C. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24: 29-43, 1988.
5. Stoll, B. A., and Secreto, G. New hormone-related markers of high risk to breast cancer. Ann. Oncol., 3: 435-438, 1992.
6. Toniolo, P. G. Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ. Health Perspect., 705 (Suppl. 3): 587-592, 1997.
7. Dorgan, J. F., Stanczyk, F. Z., Longcope, C., Stephenson, H. E., Jr., Chang, L., Miller, R., Franz, C., Falk, R. T., and Kahle, L. Relationship of serum dehydro-epiandrosterone (DHEA), DHEASulfate, and 5-androstene-3β, 17β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 6: 177-181, 1997.
8. Gail, M. H., Fears, T. R., Hoover, R. N., Chandler, D. W., Donaldson, J. L., Hyer, M. B., Pee, D., Ricker, W. V., Siiteri, P. K., Stanczyk, F. Z., Vaught, J. B., and Ziegler, R. G. Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate and progesterone. Cancer Epidemiol. Biomark. Prev., 5: 835-844, 1996.
9. Ziegler, R. G., Rossi, S. C., Fears, T. R., Bradlow, H. L.. Adlercreutz, H., Sepkovic, D., Kiuru, P., Wahala, K., Vaught, J. B., Donaldson, J. L., Falk, R. T., Fillmore, C. M., Siiteri, P. K., Hoover, R. N., and Gail, M. H. Quantifying estrogen metabolism: An evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestrone in urine. Environ. Health Perspect., 105 (Suppl. 3): 607-614, 1997.
10. Horton, R., Hawks, D., and Lobo, R. 3-α, 17-β androstanediol glucuronide in plasma: a marker of Androgen action in idiopathic hirsutism. J. Clin. Invest., 69: 1203-1206, 1982.
11. Horton, R., Imperator-McGinley, J., and Peterson, R. Androstanediol glucuronide (3 a-diol) in plasma is a unique marker in disorders of peripheral Androgen production and action in male pseudohermaphroditism. In: M. Serio and L. Martini (eds.), Sexual Differentiation, pp. 261-273. New York: Raven Press, 1984.
12. Gives, J. R. Hirsutism and hyperandrogenism. Adv. Int. Med., 21: 221-247, 1976.
13. Abraham, G. E., Maroulis, G. B., and Buster, J. E. Effect of dexamethasone on serum cortisol and Androgen levels in hirsute patients. Obstet. Gynecol., 47: 395-402, 1976.
14. Korth-Schutz, S., Virdis, R., Saenger, P., Chow, D. M., Levine, L. S., and New, M. I. Serum Androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab., 46: 452-458, 1978.
15. Buster, J. E., and Abraham, G. E. Radioimmunoassay of plasma dehydroepiandrosterone sulfate. Ann. Lett., 5: 543-547, 1972.
16. de Peretti, E., and Forest, M. G. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in humans: the use of a sensitive radioimmunoassay. J. Clin. Endocrinol. Metab., 43: 982-991, 1976.
17. Nieschlag, E., Loriaux, D. L., Ruder, H. J., Zucker, I. R., Kirschner, M. A., and Lipsett, M. B. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulfate in man. J. Endocrinol., 57: 123-134, 1973.
18. Korth-Schutz, S., Levine, L. S., and New, M. I. Dehydroepiandrosterone sulfate levels, a rapid test for abnormal adrenal Androgen secretion. J. Clin. Endocrinol. Metab., 42: 1005-1013, 1976.
19. de Peretti, E., and Forest, M. G. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J. Clin. Endocrinol. Metab., 47: 572-577, 1978.
20. Kinouchi, T., Pages, L., and Horton, R. A. A specific radioimmunoassay for testosterone in peripheral plasma. J. Lab. Clin. Med., 82: 309-316, 1973.
21. Kirschner, M., and Bardin, W. Androgen production and metabolism in normal and virilized women. Metabolism, 21: 667-688, 1972.
22. Rao, P. N., and Moore, P. H. Synthesis of new steroid haptens for radioimmunoassay. I. 15-β-carboxyethylmercapto-testosterone-bovine serum albumin conjugate. Measurement of testosterone in male plasma without chromatography. Steroids, 28: 101-109, 1976.
23. Rao, P. N., Khan, A. H., and Moore, P. H. Synthesis of new steroid haptens for radioimmunoassay. III. 15-β-carboxyethlymercaptosteroid-bovine serum albumin conjugates. Specific antisera for radioimmunoassay of 5-α-dihydrotestosterone, 5-α-androstane-3-β, 17 β-diol and 5-α-androstane-3-α, 17-β-diol. Steroids, 29: 171-184, 1977.
24. Furuyama, S., Mayes, D. M., and Nugent, C. A radioimmunoassay for plasma testosterone. Steroids, 16: 415-428, 1970.
25. Lobo, R. A., Paul, W., and Goebelsmann, U. Dehydroepiandrosterone sulfate as an indicator of adrenal Androgen function. Obstet. Gynecol., 57: 69-73, 1981.
26. Lobo, R. A., Goebelsmann, U., Brenner, P. F., and Mishell, D. R., Jr. The effects of estrogens on adrenal Androgens in oophorectomized women. Am. J. Obstet. Gynecol., 142: 471-478, 1982.
27. Goebelsmann, U., Horton, R., Mestman, J. H., and Arce, J. J. Male pseudoherm-aphroditism due to testicular 17-β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab., 36: 867-879, 1973.
28. Goebelsmann, U., Bernstein, G. S., Gale, J. A., Kletzky, O. A., Nakamura, R. M., Coulson, A. H., and Korelitz, J. J. Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: I. H. Lepow and R. Crozier (eds.), Vasectomy: Immunologic and Pathophysiologic Effects in Animals and Man, pp. 165-175. New York: Academic Press, 1979.
29. Serafini, P., Ablan, F., and Lobo, R. A. 5-α-Reductase activity in the genital skin of hirsute women. J. Clin. Endocrinol. Metab., 60: 349-355, 1985.
30. Narang, R., Rao, J., Savjani, G., Peterson, J., Gentzschein, E., and Stanczyk, F. Z. Radioimmunoassay kit for the quantitative measurement of androstanediol glucuronide in unextracted serum. Presented at the 17th National Meeting of the Clinical Ligand Assay Society, April 10-13, 1991, Chicago, IL.
31. Matteri, R. K., Stanczyk, F. Z., Gentzschein, E. E., Delgado, C., and Lobo, R. A. Androgen sulfate and glucuronide conjugates in nonhirsute women with polycystic ovarian syndrome. Am. J. Obstet. Gynecol., 161: 1704-1709, 1989.
32. SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th ed., Vol. 2, Cary, NC: SAS Institute Inc., 1989.
33. Rao, C. R. (ed.). Linear Statistical Inference and Its Applications, 2nd ed., New York: John Wiley, 1965.